Brian D. Ford - 12 Nov 2021 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jason Comerford, attorney-in fact for Mr. Ford
Issuer symbol
GRCE
Transactions as of
12 Nov 2021
Net transactions value
$0
Form type
4
Filing time
16 Nov 2021, 15:18:39 UTC
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +287,900 $0.000000 287,900 12 Nov 2021 Class A Common Shares 287,900 $1.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant.
F2 Stock options granted on 11/12/2021 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.